EnGen Bio, LLC is a biotechnology company developing therapies and vaccines designed to provide lifetime immunity against Type A influenza in both humans and animals. The company targets a novel epitope on the flu virus's M1 matrix protein to elicit broadly neutralizing antibody responses. It serves the human healthcare, veterinary, and pharmaceutical sectors.
Subscribe to see ENGEN BIO, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ENGEN BIO, LLC is a biotechnology company headquartered in Redwood City, United States. Its most recent funding round raised $632,000 in January 2020. Xcout tracks 4 named people at ENGEN BIO, LLC, including Mark Alfenito (President | CEO).
As of 16 November 2026. Source: Xcout Intel.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $632,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of ENGEN BIO, LLC's closest competitors — see the full list of competitors and alternatives →
MBF Therapeutics, Inc. is an immunotherapeutics company utilizing its proprietary T-Max DNA vaccine technology to develop next-generation treatments for animal and human health.
Axitan Holdings is a biotechnology company that develops novel endolysin-based products to target and neutralize pathogenic bacteria for the animal protein and food safety industries. Its technology provides antibiotic-free solutions to help reduce antimicrobial resistance and address key productivity issues in poultry and livestock production.
Loyal is a biotechnology company developing longevity medications designed to extend the healthspan and lifespan of dogs by targeting the underlying biological processes of aging. The company provides veterinary professionals with clinical resources, education, and trial opportunities while offering dog owners information on senior canine care and aging.
Okapi Sciences was a Belgian biotechnology company focused on discovering and developing antiviral medicines, particularly for veterinary applications and companion animals. It served the animal-health pharmaceutical market by developing treatments for viral diseases.
Pulike Biological Engineering, Inc. focuses on the entire lifecycle of animal health products, from scientific innovation and manufacturing to market distribution. The company provides a range of veterinary biologicals and pharmaceuticals, including specialized vaccines, antibodies, and medications developed for swine and poultry. Additionally, it produces various disinfectants. Its corporate headquarters are located in Luoyang, China.
ASTRA Therapeutics is a biotechnology and drug design company focused on animal health and anti-parasitic drug discovery. Located at the Swiss Innovation Park Innovaare in Villigen, Switzerland, the company leverages atomic resolution to craft next-generation small-molecule treatments against parasitic diseases.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about ENGEN BIO, LLC? Suggest a correction · Work at ENGEN BIO, LLC? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.